Veterinary Anaesthesia (Tenth Edition)

Total Page:16

File Type:pdf, Size:1020Kb

Veterinary Anaesthesia (Tenth Edition) W. B. Saunders An imprint of Harcourt Publishers Limited © Harcourt Publishers Limited 2001 is a registered trademark of Harcourt Publishers Limited The right of L.W. Hall, K.W. Clarke and C.M. Trim to be identified as the authors of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without either the prior permission of the publishers (Harcourt Publishers Limited, Harcourt Place, 32 Jamestown Road, London NW1 7BY), or a licence permitting restricted copying in the United Kingdom issued by the Copyright Licensing Agency Limited, 90 Tottenham Court Road, London W1P 0LP. First edition published in 1941 by J.G. Wright Second edition 1947 (J.G. Wright) Third edition 1948 (J.G. Wright) Fourth edition 1957 (J.G. Wright) Fifth edition 1961 (J.G. Wright and L.W. Hall) Sixth edition 1966 (L.W. Hall) Seventh edition 1971 (L.W. Hall), reprinted 1974 and 1976 Eighth edition 1983 (L.W. Hall and K.W. Clarke), reprinted 1985 and 1989 Ninth edition 1991 (L.W. Hall and K.W. Clarke) ISBN 0 7020 2035 4 Cataloguing in Publication Data: Catalogue records for this book are available from the British Library and the US Library of Congress. Note: Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs become necessary. The authors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. However, readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice. Printed in England Prelims 8/28/00 11:50 AM Page ix Preface This, the 10th edition of Veterinary Anaesthesia, is a direct descendant of Anaesthesia & Narcosis of Animals & Birds by Sir Frederick Hobday published in 1915 by Baillière, Tindall and Cox. The 1st edition of Veterinary Anaesthesia, which had marked similarities to Hobday’s book, was written by Professor J.G. Wright and published in 1942. Wright’s intention was to ‘incorporate in a small volume the present status of know- ledge on anaesthesia in the domestic animals’. This he accomplished in 198 small pages with fewer than 100 references to publications – including many to his own work. Since then tremendous advances have been made and now almost every week that passes sees new publications relating to veterinary anaesthe- sia and its related subjects.Thus, we have had to acknowledge the impossibility of including a comprehen- sive bibliography in this edition, but we have selected references which should provide a useful introduction to the literature. In addition, we have indicated where attention should be given to material published before computerized databases became available because, despite the increasing complexity of anaesthesia, simple methods also work. Although extensively revised, the general concepts remain as in previous editions. The aim is still to provide a text for undergraduate veterinary students, a reference work for veterinarians in general prac- tice and laboratory scientists, and a stimulating introduction to the subject for those wishing to specialize in veterinary anaesthesia through the examinations of the Royal College of Veterinary Surgeons, the American College of Veterinary Anesthesiologists and the European College of Veterinary Anaesthesia. Because we believe that clinical anaesthesia encompasses much more than an exercise in applied pharma- cology, emphasis is still on the effects of clinically useful doses of drugs and of practical techniques in an- imal patients, rather than on pharmacological effects demonstrated in healthy experimental animals in laboratories. We wish to express our appreciation of the invaluable help given by Mrs Lorraine Leonard, librarian of the University of Cambridge Veterinary School, and the librarians at the Royal College of Veterinary Surgeons in tracing older references. Mr Stephen Freane of the Royal Veterinary College gave much assis- tance with computer-generated figures. Finally, our warmest thanks are due to the publishers for their patience, and especially to Deborah Russell whose encouragement ensured completion of the manuscript. L.W. Hall K.W. Clarke C.M. Trim 2000 chap-1 8/28/00 10:44 AM Page 1 General considerations 1 INTRODUCTION ‘pain is the conscious perception of a noxious stimu- lus’ two conditions may be envisaged: general The clinical discipline concerned with the anaesthesia where the animal is unconscious and reversible production of insensibility to pain is apparently unaware of its surroundings, and anal- known as ‘anaesthesia’, a term coined by Oliver gesia or local anaesthesia where the animal, although Wendell Holmes in 1846 to describe a new phe- seemingly aware of its surroundings, shows nomenon in a single word. It is essentially a prac- diminished or no perception of pain. tical subject and although becoming increasingly General anaesthesia is a reversible, controlled based on science it still retains some of the attrib- drug-induced intoxication of the central nervous utes of an art. In veterinary practice anaesthesia system in which the patient neither perceives nor has to satisfy two requirements: (i) the humane recalls noxious or painful stimuli. Analgesia may handling of animals and (ii) technical efficiency. be produced by centrally acting drugs such as Humanitarian considerations dictate that gentle morphine given in doses insufficient to produce handling and restraint should always be em- unconsciousness or by substances having a local, ployed; these minimize apprehension and protect transient, selective paralytic action on sensory the struggling animal from possible injury. nerves and nerve endings (local anaesthetics). The Technical efficiency is not restricted to facilitation analgesia produced by these latter substances may of the procedure to be carried out on the animal, it be classified as local or regional, applied as they must also take into account the protection of per- are by topical application, subdermal or submu- sonnel from bites, scratches or kicks as well as the cous infiltration and by peripheral, paravertebral risks of accidental or deliberate self-injection with or spinal perineural injection. dangerous or addictive drugs. Moreover, today it The anaesthetist aims to prevent awareness of is considered that personnel need protection from pain, provide immobility and, whenever this is the possible harmful effects of breathing low con- needed, relaxation of the skeletal muscles. These centrations of inhalation anaesthetic agents. objectives must be achieved in such a way that the While anaesthesia has precisely the same mean- safety of the patient is not jeopardized during the ing as when it was first coined, i.e. the state in perianaesthetic period. Many animals fear and which an animal is insensible to pain resulting resist the restraint necessary for the administration from the trauma of surgery, it is now used much of anaesthetics thereby increasing not only the more widely and can be compared to terms such as technical difficulties of administration but also ‘illness’ and ‘shock’ which are too non-specific to the dangers inseparable from their use. A fully be of real value. Starting with the premise that conscious animal forced to breathe a strange and 1 chap-1 8/28/00 10:44 AM Page 2 2 PRINCIPLES AND PROCEDURES possibly pungent vapour struggles to escape and ‘nociceptors’ but he realized that impulses in them sympatho-adrenal stimulation greatly increases would not necessarily lead to pain sensation the risks associated with the induction of anaes- unless the central nervous system accepted them thesia. For this reason, veterinary anaesthetists and conveyed them to a pain-perceiving region of often employ sedative drugs to facilitate the com- the brain. The nociceptor fibres were found to end pletion of general anaesthesia as well as to over- preferentially on cells in laminae 1, 2 and 5 of the come the natural fear of restraint inherent in dorsal horn and from there impulses were be- animals and to control any tendency to move sud- lieved to reach the thalamus by way of spinothala- denly during operations under local analgesia. mic fibres which ran in the ventrolateral white In addition, the veterinary anaesthetist must matter of the spinal cord. From the thalamus recognize that not only does the response of each impulses were said to reach a site of pure pain sen- species of animal to the various anaesthetics differ sation (pain centre) in the association areas of the due to anatomical and physiological differences, cerebral cortex. but that there is often a marked variation in response between breeds within each particular Afferent mechanisms species. Another factor which must be considered is that in many parts of the world veterinarians In recent years pain studies have resulted in an must perform tasks without highly skilled assist- almost explosive expansion of knowledge relating ance and when employing general anaesthesia, to pain mechanisms in the body and have shown after inducing it themselves, have to depute its that these earlier ideas must be abandoned in maintenance to a nurse or even to a lay assistant. favour of an interlocking, dynamic series of bio- (It must be pointed out that in many countries, logical processes which need still further invest- including the UK, the delegation of tasks related to igation. It is apparent that in the periphery the old anaesthesia to an untrained person may in law be picture of fixed property nociceptor cells in dam- considered negligent if a mishap occurs). Thus, the aged tissue passively detecting the products of cell continued development in recent years of safe, breakdown does not accurately represent what is simple, easily applied techniques of general anaes- actually happening.
Recommended publications
  • CHRONIC PAIN in CATS Recent Advances in Clinical Assessment
    601_614_Monteiro_Chronic pain3.qxp_FAB 12/06/2019 14:59 Page 601 Journal of Feline Medicine and Surgery (2019) 21, 601–614 CLINICAL REVIEW CHRONIC PAIN IN CATS Recent advances in clinical assessment Beatriz P Monteiro and Paulo V Steagall Negative impacts of chronic pain Practical relevance: Chronic pain is a feline health and welfare issue. It has Domestic animals may now have a long life expectancy, given a negative impact on quality of life and advances in veterinary healthcare; as a consequence, there is an impairs the owner–cat bond. Chronic increased prevalence of chronic conditions associated with pain. pain can exist by itself or may be Chronic pain affects feline health and welfare. It has a negative impact associated with disease and/or injury, on quality of life (QoL) and impairs the owner–cat bond. including osteoarthritis (OA), cancer, and oral Nowadays, chronic pain assessment should be considered a funda- and periodontal disease, among others. mental part of feline practice. Clinical challenges: Chronic pain assessment Indeed, lack of knowledge on is a fundamental part of feline practice, but can be Chronic pain-related changes the subject and the use of appro- challenging due to differences in pain mechanisms in behavior are subtle and priate tools for pain recognition underlying different conditions, and the cat’s natural are some of the reasons why behavior. It relies mostly on owner-assessed likely to be suppressed analgesic administration is com- behavioral changes and time-consuming veterinary monly neglected in cats.1 consultations. Beyond OA – for which disease- in the clinical setting. In chronic pain, changes in specific clinical signs have been described – little behavior are subtle and slow, and is known regarding other feline conditions that may only be evident in the home produce chronic pain.
    [Show full text]
  • Equine Health Studies Program 2008-2010 Equine Research Report
    Equine Health Studies Program 2008-2010 Equine Research Report Scientific studies conducted to help advance equine health and well-being LETTER FROM OUR DEAN The Louisiana State University School of Veterinary Medicine is pleased to once again present the Equine Health Studies Program’s Equine Research Report, which covers scientific activities of the program from 2008 through 2010. Central to the program’s mission is the health, well- being and performance of horses supported through state- of-the-art research that benefits the horse-owning public in Louisiana and beyond. As a former equine surgeon and faculty member, I have watched the EHSP grow and flourish, as evidenced by contents of this Research Report, translating research into practical solutions for our broad- base constituents and clients. In addition to its research prowess, the program’s dedicated faculty and staff provide clinical service, education, and community outreach. The EHSP has made significant advances in research collaborations with industry to extend its work in the areas of laminitis prevention; lameness, orthopedics and biomechanics; reproductive disorders; respiratory and gastrointestinal diseases including the treatment and prevention of gastric ulcer disease; equine Cushing’s disease; and surgery that will impact equine veterinary care for years to come. The EHSP continues to build and maintain strong relationships and community engagement with the stakeholders of Louisiana so that it can be responsive to the needs of horses in the region. In the aftermath of Hurricanes Gustav and Ike and the Gulf Oil Spill, the SVM was able to step in and help with the rescue and care of animals and wildlife in south Louisiana.
    [Show full text]
  • Hospital Standards Self-Evaluation Checklist
    Hospital Standards Self-Evaluation Checklist July 2017 The Hospital Standards Self-Evaluation Checklist was developed by the Veterinary Medical Board (Board) and its Multidisciplinary Advisory Committee with input from the public and profession in order to assist Hospital Directors’ review of minimum standards to achieve compliance with the law. The Board strongly recommends involvement of the entire staf in a team efort to become familiar with and maintain the minimum standards of practice. Contents INTRODUCTION 1 GENERAL 3 1. After Hours Referral/Hospital Closure. 3 2. License/Permit Displayed . 4 3. Correct Address . 6 4. Notice of No Staff on Premises . 7 FACILITIES 9 5. General Sanitary Conditionsn . 9 6. Temperature and Ventilation. 10 7. Lighting . 10 8. Reception/Offce . 10 9. Exam Rooms . 11 10. Food & Beverage . 11 11. Fire Precautions . 12 12. Oxygen Equipment . 13 13. Emergency Drugs and Equipment. 13 14. Laboratory Services . 13 15. X-ray . 14 16. X-ray Identifcation. 15 17. X-ray Safety Training for Unregistered Assistants . 16 1 8. Waste Disposal . 16 19. Disposal of Animals . 17 20. Freezer. 17 21. Compartments . 18 22. Exercise Runs . 18 23. Contagious Facilities. 19 SURGERY 21 24. Separate Surgery . 21 25. Surgery Lighting/X-ray/Emergency . 22 26. Surgery Floors, Tables and Countertop . 23 27. Endotracheal Tubes . 23 28. Resuscitation Bags . 23 29. Anesthetic Equipment . 24 30. Anesthetic Monitoring . 24 31. Surgical Packs and Sterile Indicators . 25 32. Sterilization of Equipment . 26 33. Sanitary Attire . 26 Hospital Standards Self-Evaluation Checklist i DANGEROUS DRUGS/CONTROLLED SUBSTANCES 29 34. Expired Drug. 29 35. Drug Security Controls .
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • 001-017-Anesthesia.Pdf
    Current Fluid Therapy Topics and Recommendations During Anesthetic Procedures Andrew Claude, DVM, DACVAA Mississippi State University Mississippi State, MS • Intravenous fluid administration is recommended during general anesthesia, even during short procedures. • The traditional IV fluid rate of 10 mls/kg/hr during general anesthesia is under review. • Knowledge of a variety of IV fluids, and their applications, is essential when choosing anesthetic protocols for different medical procedures. Anesthetic drug effects on the cardiovascular system • Almost all anesthetic drugs have the potential to adversely affect the cardiovascular system. • General anesthetic vapors (isoflurane, sevoflurane) cause a dose-dependent, peripheral vasodilation. • Alpha-2 agonists initially cause peripheral hypertension with reflex bradycardia leading to a dose-dependent decreased patient cardiac index. As the drug effects wane, centrally mediated bradycardia and hypotension are common side effects. • Phenothiazine (acepromazine) tranquilizers are central dopamine and peripheral alpha receptor antagonists. This family of drugs produces dose-dependent sedation and peripheral vasodilation (hypotension). • Dissociative NMDA antagonists (ketamine, tiletamine) increase sympathetic tone soon after administration. When dissociative NMDA antagonists are used as induction agents in patients with sympathetic exhaustion or decreased cardiac reserve (morbidly ill patients), these drugs could further depress myocardial contractility. • Propofol can depress both myocardial contractility and vascular tone resulting in marked hypotension. Propofol’s negative effects on the cardiovascular system can be especially problematic in ill patients. • Potent mu agonist opioids can enhance vagally induced bradycardia. Why is IV fluid therapy important during general anesthesia? • Cardiac output (CO) equals heart rate (HR) X stroke volume (SV); IV fluids help maintain adequate fluid volume, preload, and sufficient cardiac output.
    [Show full text]
  • Un Novedoso Enfoque Para El Diseño De Fármacos Antimicrobianos Asistido Por Computadora
    TOMOCOMD-CARDD: Un Novedoso Enfoque para el Diseño de Fármacos Antimicrobianos Asistido por Computadora Autora: Yasnay Valdés Rodríguez. Tutores: Prof. Dr. Yovani Marrero Ponce. Prof. MSc. Ricardo Medina Marrero. 2005-2006 La ignorancia afirma o niega rotundamente; la ciencia duda… Voltaire (1694-1778) Quiero dedicar este trabajo a todas aquellas personas que me aprecian y desean lo mejor para mi, especialmente a mis padres. A mi padre Dedico este trabajo con mucho amor, por hacerme comprender que siempre se puede llegar mas lejos, y que no hay nada imposible, solamente hay que luchar... A mi madre Por su infinita bondad, por su sacrificio inigualable. A mis familiares Por todo su apoyo y ayuda que me han mostrado incondicionalmente. A mi hermano Por ser mi fuente de inspiración. A la humanidad “...porque si supiera que el mundo se acaba mañana, yo, hoy todavía, plantaría un árbol” Quiero agradecer a todas aquellas personas que me han ayudado a realizar este sueño: A mis padres por todo el sacrificio realizado, y aún parecerles poco, los amo mucho. A mi madre por estar siempre a mi lado en los buenos y malos momentos ayudándome a levantarme en cualquier recaída. A mi padre por guiarme en la vida y brindarme sus consejos siempre útiles, por darme fuerza y vitalidad. A mi mayor tesoro, mi hermano, que me alumbra de esperanza día a día. A mis tías y primos que me ayudaron mucho, aún estando lejos. A mi novio que me apoyo en todas mis decisiones y con paciencia supo ayudarme. A mis tutores y cotutores que siempre me dieron la mano; especialmente a Yovani por su paciencia, a quien debo gran parte de mi formación como profesional por sus exigencias.
    [Show full text]
  • Muscle Relaxants
    Muscle relaxants ●cause relaxation of striated (voluntary skeletal) musculature (in contrast to spasmolytics which relax unstriped musculature) Classification of myorelaxants 1. Neuromuscular blocking drugs ●periferial (direct) myorelaxants: interact with acetylcholine nicotinic (N) receptors of skeletal musculature a) stabilizing myorelaxants – N-receptors antagonists b) depolarizing myorelaxants – N-receptors agonists ●continuous N-receptors stimulation depolarization of cells functional antagonism: further leading of impulses imposible, no muscle contraction c) indirect myorelaxants: botulinum toxin ●irreversibly inhibits acetycholine releasing 2. Central muscle relaxants ●acts in CNS ●structurally heterogenic group ●compounds with various mechanisms of action Stabilizing myorelaxants ●N-receptors antagonists in skeletal muscle cells ●usage: surgical operative measures (often as a part of some form of anaesthesia) ●structures derived from curare alkaloids Curare: arrow poison of South American Indians ●preparation from various plants ●contained a complex mixture of alkaloids Curare classification: according to preparation and package in which it was shipped to Europe 1. Tubocurare: in hollow bamboo rods 2. Calebase curare: in bottle-shaped cucurbits (gourds, calabashes - from plants of genus Strychnos) 3. Pot curare: in ceramic vessels Structural types: 1. Benzyltetrahydroisoquinolines: tubocurarine (from tubocurare) atracurium besylate (synthetic) mivacurium besylate (synthetic) etc. 2. Indole derivatives: toxiferine C alcuronium chloride 3. Steroids with basic substituents: vecuronium bromide pancuronium bromide rocuronium bromide 1. Benzyltetrahydroisoquinolines H3C O H C O O CH3 3 H3C H + H3C H C O O H3C N O 3 OH H C 3 O O H3C H H H + CH + N 3 O O N OH O CH3 N CH3 O O O H3C O CH3 O CH3 tubocurarine atracurium ●used as besylate Tracrium ® inj.
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • Xerox University Microfilms
    INFORMATION TO USERS This material was produced from a microfilm copy of the original document. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the original submitted. The following explanation of techniques is provided to help you understand markings or patterns which may appear on this reproduction. 1.The sign or "target" for pages apparently lacking from the document photographed is "Missing Page(s)". If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting thru an image and duplicating adjacent pages to insure you complete continuity. 2. When an image on the film is obliterated with a large round black mark, it is an indication that the photographer suspected that the copy may have moved during exposure and thus cause a blurred image. You will find a good image of the page in the adjacent frame. 3. When a map, drawing or chart, etc., was part of the material being photographed the photographer followed a definite method in "sectioning" the material. It is customary to begin photoing at the upper left hand corner of a large sheet and to continue photoing from left to right in equal sections with a small overlap. If necessary, sectioning is continued again — beginning below the first row and continuing on until complete. 4. The majority of users indicate that the textual content is of greatest value, however, a somewhat higher quality reproduction could be made from "photographs" if essential to the understanding of the dissertation.
    [Show full text]
  • Central Nervous Systems’ Effects of Isoflurane
    CENTRAL NERVOUS SYSTEMS' EFFECTS OF ISOFLURANE (FORANE) EVA M. KAVAN, M.D. AND ROBERT M. JULIEN, PH.D. INTRODUCTION [SOFLUBANE (Forane,* 1-chloro-2,2,2,-trifluoroethyl difluoromethyl ether (is a re- cently developed short-chain halogenated inhalation agent. It is an isomer of enflu- rane, with a different boiling point and vapour pressure? Isoflurane provides rapid induction as well as prompt emergence from anaesthesia. Isoflurane-induced an- aesthesia has been investigated in experimental animals 2-4 and in man. ~-8 Its effects on the cortical EEG have been determined in dogs, 4 in human volunteers 7 and in patients during operations. 8 However, the effects of isoflurane on subcortical struc- tures have not been investigated. The present study was conducted to supply these data. METHODS A. Chronic Experiments Five cats (average weight 4.8 kg) were used in eight experiments. Under pento- barbital anaesthesia, using sterile technique, bipolar concentric stainless steel elec- trodes (0.2 mm diameter) were implanted stereotaxically9 into the following struc- tures: 11. caudatus (CAUD), n. ventralis postero-lateralis (primary relay nucleus) of the thalamus (VPL), the midbrain reticular formation (RF), n. centrum medi- anum (CM), n. amygdalae (AMYG) and formatio hippocampi (HIPP). Stainless steel screws were imbedded in the skull over frontal and parietal cortices. Leads from all electrodes were soldered to miniature Winchester sockets which were secured to the skull with acrylic resin. Two weeks after implantation, the cats were taken to the laboratory for condi- tioning and control tracings. In the following week, isoflurane vapourized through a copper kettle was administered by mask, using a total of 1 L/rain flow of equal parts of air and oxygen in a semiclosed system.
    [Show full text]
  • Proceedings of the Anaesthetic Research Society Glasgow Meeting July 7, 1979
    Br.J. Anaesth. (1979), 51-, 989P PROCEEDINGS OF THE ANAESTHETIC RESEARCH SOCIETY GLASGOW MEETING JULY 7, 1979 EFFECT OF KETAMINE ON TRANSMISSION a 50% depression in the response to carbachol 5.46 x 10~6 1 5 IN SYMPATHETIC GANGLIA mol litre" was determined (IC50 ketamine = 8.5 x 10" 1 mol litre" , r = 0.83). Downloaded from https://academic.oup.com/bja/article/51/10/989/304330 by guest on 29 September 2021 V. MAHMOODI, A. J. BYRNE, T. E. J. HEALY AND In the concentrations used ketamine has been shown to S. Z. HUSSAIN interfere with the sympathetic final common pathway but Department of Surgery {Anaesthesia), Queen's Medical the results do not preclude a central effect at lower con- Centre, University Hospital, Clifton Boulevard, centrations. Nottingham ACKNOWLEDGEMENT An increase in arterial pressure following the injection of We gratefully acknowledge financial support from Parke ketamine is well documented and has been explained by Davis and Co. both central (Ivankovich et al., 1974) and peripheral actions (Nedergaard, 1973). The sympathetic division of REFERENCES the autonomic nervous system is the link between central Hukovic, S. (1961). Br. J. Pharmacol, 16, 188. and peripheral mechanisms for increasing arterial pressure. Ivankovich, A. D., Miletich, D. J., Reimann, C, Albrecht, It was therefore decided to investigate the effects of keta- R. F., and Zahed, B. (1974). Anesth. Analg. {Cleve.), 53, mine on this final common pathway. 924. The hypogastric nerve, hypogastric plexus and vas Nedergaard, O. A. (1973). Eur. J. Pharmacol, 23, 153. deferens of adult guineapigs were dissected (Hukovic, 1961) and mounted in Krebs' solution bubbled with oxygen 95% and carbon dioxide 5% at 32 °C.
    [Show full text]
  • De Fármacos Antimaláricos
    Facultad de Química-Farmacia Centro de Bioactivos Químicos TOMOCOMD-CARDD: Un Novedoso Enfoque para el Diseño ‘Racional In- Silico’ de Fármacos Antimaláricos Tesis presentada en opción al grado de Licenciado en Ciencias Farmacéuticas. Autor: Carlos Ricardo Romero Zaldivar Tutores: Prof. Inst., Lic. Yovani Marrero Ponce, M.Sc. Prof. Asist., Lic. Maité Iyarreta Veitía, Ph.D. Santa Clara 2004 RESUMEN Nuevos descriptores moleculares útiles para el diseño “racional in silico” de fármacos han sido aplicados a la modelación de la actividad antimalárica. El cálculo de los nuevos índices moleculares fue implementado en el programa TOMOCOMD-CARDD (TOpological MOlecular COMputer Design-Computed Aided ‘Rational’ Drug Design). Los índices cuadráticos y lineales (estocásticos y no estocásticos) fueron usados junto con el análisis discriminante lineal (ADL) para desarrollar modelos QSAR-ADL que permitan la correcta predicción de la actividad antimalárica. Los modelos obtenidos describen adecuadamente la actividad biológica estudiada y en todos los casos clasifican correctamente más del 90.00% de los compuestos en la serie de entrenamiento. En orden de acceder a la robustez y al poder predictivo de los modelos encontrados, procedimientos de validación cruzada interna y externa fueron utilizados. Estas aproximaciones permiten obtener una adecuada explicación de la actividad antimalárica basado en rasgos estructurales evidenciando el rol preponderante de los enlaces de hidrógenos, la presencia de heteroátomos y de las propiedades relacionadas con el tamaño molecular en las interacciones con los sitios dianas antimaláricos. Posteriormente, los modelos desarrollados fueron usados en la simulación de una búsqueda virtual de inhibidores de la farnesil-transferasa (H-Ras) con actividad antimalárica; 84.61% de los inhibidores de la H-Ras usados en esta búsqueda virtual fueron correctamente clasificados por las modelos QSAR-ADL, indicando la habilidad del método TOMOCOMD-CARDD para el descubrimiento de nuevos compuestos líderes con nuevos mecanismos de acción.
    [Show full text]